(Q38969661)

English

Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Use of VEGFR-2 targeted ultrasound contrast agent for the early evaluation of response to sorafenib in a mouse model of hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

based on heuristic

inferred from title

Marco Baron Toaldo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Maddalena Milazzo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Fabio Piscaglia

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Veronica Salvatore

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Chiara Palamà

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Luca Croci

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Laura Venerandi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Mario Cipone

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Luigi Bolondi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

publication date

1 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Molecular Imaging and Biology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

29-37

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Epidemiology of viral hepatitis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Assessment of the treatment response of HCC.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectives.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Non-invasive imaging for studying anti-angiogenic therapy effects.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Tumor angiogenesis: molecular pathways and therapeutic targets

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Overcoming resistance to antiangiogenic therapies

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Molecular ultrasound assessment of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

How molecular imaging is speeding up antiangiogenic drug development

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Molecularly targeted therapy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Prognostic significance and potential therapeutic target of VEGFR2 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

MAP kinase signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Stimulatory effects of the multi-kinase inhibitor sorafenib on human bladder cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

Dose translation from animal to human studies revisited

1 reference

https://api.crossref.org/works/10.1007%2FS11307-014-0764-X

21 January 2018

A comparative evaluation of ultrasound molecular imaging, perfusion imaging, and volume measurements in evaluating response to therapy in patient-derived xenografts

1 reference

https://pubmed.ncbi.nlm.nih.gov/25082536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ultrasound for molecular imaging and therapy in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25082536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modes of resistance to anti-angiogenic therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25082536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).

1 reference

https://pubmed.ncbi.nlm.nih.gov/25082536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermediate and advanced hepatocellular carcinoma treated with the antiangiogenic agent sorafenib. Evaluation with unenhanced and contrast-enhanced ultrasonography

1 reference

https://pubmed.ncbi.nlm.nih.gov/25082536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fast microbubble dwell-time based ultrasonic molecular imaging approach for quantification and monitoring of angiogenesis in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25082536

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-014-0764-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25082536%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38969661&oldid=2202396503"